127 related articles for article (PubMed ID: 11322930)
1. Novel modified adenosine 5'-triphosphate analogues pharmacologically characterized in human embryonic kidney 293 cells highly expressing rat brain P2Y(1) receptor: Biotinylated analogue potentially suitable for specific P2Y(1) receptor isolation.
Zündorf G; Schäfer R; Vöhringer C; Halbfinger E; Fischer B; Reiser G
Biochem Pharmacol; 2001 May; 61(10):1259-69. PubMed ID: 11322930
[TBL] [Abstract][Full Text] [Related]
2. Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.
Ravi RG; Kim HS; Servos J; Zimmermann H; Lee K; Maddileti S; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 May; 45(10):2090-100. PubMed ID: 11985476
[TBL] [Abstract][Full Text] [Related]
3. Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5'-O-(1-boranotriphosphate) derivatives.
Tulapurkar ME; Laubinger W; Nahum V; Fischer B; Reiser G
Br J Pharmacol; 2004 Jul; 142(5):869-78. PubMed ID: 15197109
[TBL] [Abstract][Full Text] [Related]
4. Sp-2-propylthio-ATP-α-B and Sp-2-propylthio-ATP-α-B,β-γ-dichloromethylene are novel potent and specific agonists of the human P2Y₁₁ receptor.
Haas M; Ben-Moshe I; Fischer B; Reiser G
Biochem Pharmacol; 2013 Sep; 86(5):645-55. PubMed ID: 23810430
[TBL] [Abstract][Full Text] [Related]
5. A chimeric rat brain P2Y1 receptor tagged with green-fluorescent protein: high-affinity ligand recognition of adenosine diphosphates and triphosphates and selectivity identical to that of the wild-type receptor.
Vöhringer C; Schäfer R; Reiser G
Biochem Pharmacol; 2000 Apr; 59(7):791-800. PubMed ID: 10718337
[TBL] [Abstract][Full Text] [Related]
6. Adenosine 5'-O-(1-boranotriphosphate) derivatives as novel P2Y(1) receptor agonists.
Nahum V; Zündorf G; Lévesque SA; Beaudoin AR; Reiser G; Fischer B
J Med Chem; 2002 Nov; 45(24):5384-96. PubMed ID: 12431066
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor.
Takasaki J; Kamohara M; Saito T; Matsumoto M; Matsumoto S; Ohishi T; Soga T; Matsushime H; Furuichi K
Mol Pharmacol; 2001 Sep; 60(3):432-9. PubMed ID: 11502873
[TBL] [Abstract][Full Text] [Related]
8. Characterization of [35S]-ATP alpha S and [3H]-alpha, beta-MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations.
Schäfer R; Reiser G
Br J Pharmacol; 1997 Jul; 121(5):913-22. PubMed ID: 9222547
[TBL] [Abstract][Full Text] [Related]
9. The P2Y(1) receptor closes the N-type Ca(2+) channel in neurones, with both adenosine triphosphates and diphosphates as potent agonists.
Filippov AK; Brown DA; Barnard EA
Br J Pharmacol; 2000 Mar; 129(6):1063-6. PubMed ID: 10725253
[TBL] [Abstract][Full Text] [Related]
10. Agonist action of adenosine triphosphates at the human P2Y1 receptor.
Palmer RK; Boyer JL; Schachter JB; Nicholas RA; Harden TK
Mol Pharmacol; 1998 Dec; 54(6):1118-23. PubMed ID: 9855642
[TBL] [Abstract][Full Text] [Related]
11. HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors.
Schachter JB; Sromek SM; Nicholas RA; Harden TK
Neuropharmacology; 1997 Sep; 36(9):1181-7. PubMed ID: 9364473
[TBL] [Abstract][Full Text] [Related]
12. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
[TBL] [Abstract][Full Text] [Related]
13. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
[TBL] [Abstract][Full Text] [Related]
14. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
Horiuchi T; Dietrich HH; Hongo K; Dacey RG
Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
[TBL] [Abstract][Full Text] [Related]
15. 2-Thioether-5'-O-(1-thiotriphosphate)-adenosine derivatives: new insulin secretagogues acting through P2Y-receptors.
Fischer B; Shahar L; Chulkin A; Boyer JL; Harden KT; Gendron FP; Beaudoin AR; Chapal J; Hillaire-Buys D; Petit P
Isr Med Assoc J; 2000 Jul; 2 Suppl():92-8. PubMed ID: 10909425
[TBL] [Abstract][Full Text] [Related]
16. An examination of deoxyadenosine 5'(alpha-thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1 receptor.
Schachter JB; Harden TK
Br J Pharmacol; 1997 May; 121(2):338-44. PubMed ID: 9154346
[TBL] [Abstract][Full Text] [Related]
17. Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
Mohanty JG; Raible DG; McDermott LJ; Pelleg A; Schulman ES
J Allergy Clin Immunol; 2001 May; 107(5):849-55. PubMed ID: 11344352
[TBL] [Abstract][Full Text] [Related]
18. Adenine triphosphate nucleotides are antagonists at the P2Y receptor.
Kauffenstein G; Hechler B; Cazenave JP; Gachet C
J Thromb Haemost; 2004 Nov; 2(11):1980-8. PubMed ID: 15550030
[TBL] [Abstract][Full Text] [Related]
19. Molecular recognition of modified adenine nucleotides by the P2Y(1)-receptor. 1. A synthetic, biochemical, and NMR approach.
Halbfinger E; Major DT; Ritzmann M; Ubl J; Reiser G; Boyer JL; Harden KT; Fischer B
J Med Chem; 1999 Dec; 42(26):5325-37. PubMed ID: 10639276
[TBL] [Abstract][Full Text] [Related]
20. P2Y receptor mediated modulation of insulin release by a novel generation of 2-substituted-5'-O-(1-boranotriphosphate)-adenosine analogues.
Farret A; Filhol R; Linck N; Manteghetti M; Vignon J; Gross R; Petit P
Pharm Res; 2006 Nov; 23(11):2665-71. PubMed ID: 17048117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
